DRI Capital Inc, based in Toronto, ON, is a pioneer in Pharmaceutical Royalty Monetization. Specializing in building a diversified portfolio of interests in medicines, the company focuses on products that effectively treat and address unmet medical needs.
With tailored offerings, DRI Capital Inc serves as a best-in-class partner for investors and innovators. The company prides itself on multiple repeat deal partners and offers unique, creative, and flexible structures to meet the needs of its counterparts.
As a smart capital allocator, DRI Capital Inc acquires dependable, patent-protected cash flow streams from the sales of significant drugs across various therapeutic areas. By actively sourcing royalty streams on medically necessary products with long-term patent protection and high growth potential, the company drives value creation for its portfolio and investors.
Generated from the website content
